Research and Development

Showing 15 posts of 9573 posts found.

andrew_cheng

Gilead CMO announces departure alongside two new exec appointments

August 17, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its Chief Medical Officer is to vacate the role after just five months and leave the …
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 17, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, CMO, Litigation, OxyContin, Purdue Pharma, approvals, top 10

This week’s pharmaceutical headlines were dominated by legal spats as the state of New York sued OxyContin drug maker Purdue …
blood-75301_640

“Triple pill” blood pressure combo proves more effective, safe than standard care

August 16, 2018 Research and Development blood pressure, heart attack, heart disease, pharma, triple pill

A “triple pill” combining three established and effective drugs at low dosage levels could prove much more effective in treating …
6813384933_1fb31d73fb_z

Ibalisumab effective in in treating multidrug resistant HIV

August 16, 2018 Research and Development AIDS, HIV, multidrug resistance, phase 3

The monoclonal antibody Ibalizumab has shown significant antiviral activity against multidrug resistant HIV infections, according to the results of a …
1280px-old_surgical_hospital_drummond_street

Regenerative process could be restored in liver after severe injuries, study shows

August 16, 2018 Research and Development Edinburgh University, liver, mice, research, transplants

Scientists at the University of Edinburgh were able to restore a regenerative response that prevented the need for a liver …

Pfizer partners up with BioNTech for $425m to pursue mRNA flu vaccines

August 16, 2018 Research and Development BioNTech, Pfizer, Vaccine, flu, influenza, pharma

Pfizer has announced a partnership with German biotech firm BioNTech after signing a multi-year deal worth $425 million to develop …

Realm Therapeutics shares halved after failure of Phase 2 study

August 15, 2018 Research and Development London, Shares, atopic dermatitis, phase 2, stock market

Shares in the London-listed Realm Therapeutics plummeted on Monday after the company reported that a Phase II study of the …

Janssen and ViiV’s monthly injectable HIV combo proves non-inferior to daily standard of care

August 15, 2018 Research and Development HIV, Janssen, ViiV Healthcare, pharma

Janssen and GSK’s ViiV Healthcare have unveiled strong new Phase 3 data on its two-drug regimen, injected once a month, …

Rotavirus vaccine shown to reduce risk of death by 34% in Malawi

August 15, 2018 Research and Development Rotavirus, diarrhoea, malawi, vaccination program, vaccines

A rotavirus vaccine was successful in reducing diarrhoea related deaths in infants in Malawi by 34%, a study led by …

New York sues Purdue Pharma over opioid crisis

August 15, 2018 Research and Development Litigation, New York, OxyContin, Purude pharma, opioid crisis, state

New York State have sued OxyContin drug maker Purdue Pharma over allegations surrounding widespread fraud and deception in the marketing …
gilead-sciences

Gilead CMO announces departure alongside two new exec appointments

August 15, 2018 Medical Communications, Research and Development Gilead, pharma

Gilead has announced that its Chief Medical Officer is to vacate the role after just five months and leave the …
nawal_ouzren_-_sensorion_alt

Working Life: Nawal Ouzren, CEO of Sensorion

August 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Sensorion, Working Life, feature, pharma

Pharmafocus caught up with Sensorion CEO Nawal Ouzren to take a look at her path throughout her career and get …
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ADHD, Allergan, MHRA, UK, brexit, iraq, pharma, top 10

There was some clarity on Brexit this week as the MHRA set out a plan for the implantation period set …
rep

US Congressman arrested over insider trading in biopharma firm

August 9, 2018 Research and Development, Sales and Marketing Chris Collins, Innate, Innate Immunotherapeutics, US, congress, multiple sclerosis, pharma

A Republican Congressman has been arrested by the FBI over on charges of insider trading with shares in Australian biopharmaceutical …

NICE recommends Eli Lilly’s psoriatic arthritis drug

August 9, 2018 Research and Development, Sales and Marketing Eli Lilly, England, NICE, Wales, psoriatic arthritis

Eli Lilly have announced that the monoclonal antibody ixekizumab, has been recommended by NICE for use as a treatment option …
The Gateway to Local Adoption Series

Latest content